We are live on ! Find out more
HPC

HM Payson & Co Portfolio holdings

AUM $7.54B
1-Year Est. Return 31.34%
This Fund
S&P 500
This Quarter Est. Return
+7.12%
1 Year Est. Return
+31.34%
3 Year Est. Return
+94.39%
5 Year Est. Return
+124.39%
10 Year Est. Return
+419.98%
AUM
$4.1B
AUM Growth
+$346M
Cap. Flow
+$98.2M
Cap. Flow %
2.39%
Top 10 Hldgs %
28.43%
Holding
1,220
New
75
Increased
171
Reduced
308
Closed
104

Top Buys

Rank Stock Value
1
AON icon
Aon
AON
+$24.5M
2
WU icon
Western Union
WU
+$13.5M
3
JPST icon
JPMorgan Ultra-Short Income ETF
JPST
+$12.3M
4
LH icon
Labcorp
LH
+$11.5M
5
AVGO icon
Broadcom
AVGO
+$8.02M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$14.5M
2
GNRC icon
Generac Holdings
GNRC
+$9.38M
3
AAPL icon
Apple
AAPL
+$6.23M
4
MSFT icon
Microsoft
MSFT
+$3.53M
5
HAS icon
Hasbro
HAS
+$3.46M

Sector Composition

Rank Sector Weight
1 Technology 25.55%
2 Healthcare 16.77%
3 Financials 13.8%
4 Consumer Discretionary 11.07%
5 Industrials 9.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CVNA icon
1101
Carvana
CVNA
$43.3B
-3,350
Closed -$176K
DNLI icon
1102
Denali Therapeutics
DNLI
$3.67B
-1,013
Closed -$58K
DNTH icon
1103
Dianthus Therapeutics
DNTH
$5.68B
-89
Closed -$17K
EEMV icon
1104
iShares MSCI Emerging Markets Min Vol Factor ETF
EEMV
$3.45B
-368
Closed -$23K
EFAV icon
1105
iShares MSCI EAFE Min Vol Factor ETF
EFAV
$5.22B
-307
Closed -$22K
EMLC icon
1106
VanEck JP Morgan EM Local Currency Bond ETF
EMLC
$4.74B
$0 ﹤0.01%
2
-20
-91% -$630
ENPH icon
1107
Enphase Energy
ENPH
$4.84B
-639
Closed -$104K
EPAM icon
1108
EPAM Systems
EPAM
$4.69B
-168
Closed -$67K
EQT icon
1109
EQT Corp
EQT
$33.2B
-325
Closed -$6K
FDEM icon
1110
Fidelity Emerging Markets Multifactor ETF
FDEM
$563M
-200
Closed -$6K
FND icon
1111
Floor & Decor
FND
$5.81B
-395
Closed -$38K
FNDC icon
1112
Schwab Fundamental International Small Company Index ETF
FNDC
$3.01B
$0 ﹤0.01%
9
-231
-96% -$9.09K
FOLD
1113
DELISTED
Amicus Therapeutics
FOLD
-845
Closed -$8K
FPE icon
1114
First Trust Preferred Securities and Income ETF
FPE
$6.3B
-267
Closed -$5K
FQAL icon
1115
Fidelity Quality Factor ETF
FQAL
$1.41B
-150
Closed -$7K
FRI icon
1116
First Trust S&P REIT Index Fund
FRI
$195M
-458
Closed -$12K
FVAL icon
1117
Fidelity Value Factor ETF
FVAL
$1.28B
-150
Closed -$7K
FXO icon
1118
First Trust Financials AlphaDEX Fund
FXO
$1.12B
-345
Closed -$14K
GALT icon
1119
Galectin Therapeutics
GALT
$229M
-3,252
Closed -$7K
GERN icon
1120
Geron
GERN
$911M
$0 ﹤0.01%
340
GKOS icon
1121
Glaukos
GKOS
$9.02B
-296
Closed -$25K
GLPI icon
1122
Gaming and Leisure Properties
GLPI
$12.8B
$0 ﹤0.01%
1
HAUZ icon
1123
Xtrackers International Real Estate ETF
HAUZ
$1.04B
-1
Closed
HCA icon
1124
HCA Healthcare
HCA
$84.8B
$0 ﹤0.01%
2
IEV icon
1125
iShares Europe ETF
IEV
$1.63B
-50
Closed -$3K

Similar funds

HM Payson & Co's Q2 2021 Portfolio in Review

As of Q2 2021, HM Payson & Co held 1,220 positions worth $4.1B, up 9.2% from $3.76B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

HM Payson & Co's Q2 2021 filing shows 75 new, 171 increased, 308 reduced and 104 closed positions. Its largest new stake was Vanguard Ultra-Short Bond ETF: 62,900 shares worth $3.15M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $14.5M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.

  • HM Payson & Co's largest Q2 2021 buy was Vanguard Ultra-Short Bond ETF: 62,900 shares worth $3.15M.
  • HM Payson & Co added most to Aon in Q2 2021, an estimated $24.5M increase.
  • HM Payson & Co's biggest Q2 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $14.5M.
  • HM Payson & Co fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $1.66M.
  • HM Payson & Co's ten largest holdings make up 28% of its $4.1B portfolio in Q2 2021.
  • HM Payson & Co opened 75 new positions and closed 104 in Q2 2021.
  • HM Payson & Co's portfolio value rose 9.2% quarter-over-quarter to $4.1B.

Based on HM Payson & Co's 13F filing for Q2 2021, filed 17 Aug 2021.